Report of Foreign Issuer (6-k)
November 14 2019 - 6:28AM
Edgar (US Regulatory)
FORM 6-K
________________________________________
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
Commission File Number: 001-38757
For the month of November 2019
________________________________________
TAKEDA PHARMACEUTICAL COMPANY LIMITED
(Translation of registrant’s name into English)
________________________________________
1-1, Nihonbashi-Honcho 2-Chome
Chuo-ku, Tokyo 103-8668
Japan
(Address of principal executive offices)
________________________________________
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Information furnished on this form:
EXHIBIT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TAKEDA PHARMACEUTICAL COMPANY LIMITED
|
|
|
|
|
|
|
Date: November 14, 2019
|
|
|
|
By:
|
|
/s/ Takashi Okubo
|
|
|
|
|
|
|
|
Takashi Okubo
Global Head of Investor Relations
|
Takeda Pharmaceutical (PK) (USOTC:TKPHF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Takeda Pharmaceutical (PK) (USOTC:TKPHF)
Historical Stock Chart
From Apr 2023 to Apr 2024
